InvestorsHub Logo
Followers 72
Posts 6198
Boards Moderated 0
Alias Born 05/01/2011

Re: rosemountbomber post# 228666

Wednesday, 11/20/2019 9:09:00 AM

Wednesday, November 20, 2019 9:09:00 AM

Post# of 424415
My assumptions kick out earnings of just shy of half of that, or around $3.7bn, which would be about $9 per share fully diluted. Keep in mind that margins for a big BP bolting this on would be better than AMRN GIA margins.

I don't think you can value AMRN on P/E multiples though. At the moment they have a single drug with a defined lifetime. If they had an actual viable pipeline it would be very different.

I'm really feeling $50 to $60 PPS is the kill zone here.

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News